Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Vision recovery similar at 30 days, consistent with other recent randomized studies ...

This interview is a translation of a video blog posted on Medscape France. It has been edited for clarity. Philippe Gabriel Steg, MD: Hello. Today, I would like to address a subject that many ...

Retinal vascular occlusion affects the eye, specifically the retina. The retina is the light-sensitive layer of tissue that lines the back of your eye. It’s covered with special cells called rods and ...

Please provide your email address to receive an email when new articles are posted on . The mean time to treatment was 2.5 hours after presentation. Initial outcomes demonstrated significant ...

Lupus can affect multiple parts of the body, including the eyes. Researchers looked at the case of a young woman who came to the hospital after experiencing sudden, painless vision loss in her right ...

Intravenous tenecteplase does not improve vision recovery and is associated with greater incidence of adverse events ...

Central retinal artery occlusion (CRAO) is a sight‐threatening condition characterised by the abrupt interruption of blood flow to the retina. The resultant ischaemia precipitates sudden, painless ...